Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Patents and Formulation Strategies for Osmotic Controlled Drug Delivery Systems: A Comprehensive Analysis.

Recent advances in drug delivery and formulation·2025
Same author

Exploring the Multifaceted Health Benefits of Natural Dietary Sources: Antimicrobial, Antioxidant, Anticancer, and Antidiabetic Properties.

Recent patents on biotechnology·2025
Same author

Nano-Rutin: A Promising Solution for Alleviating Various Disorders.

Recent patents on nanotechnology·2024
Same author

Transfersomes: Recent Advances, Mechanisms, Exhaustive Applications, Clinical Trials, and Patents.

Current drug delivery·2024
Same author

Role of Nanoformulations in the Treatment of Lung Cancer.

Recent patents on nanotechnology·2024
Same author

WITHDRAWN: Wheatgrass (Triticum aestivum) Extract Loaded Chitosan Solid Lipid Nanoparticles: Formulation, Physicochemical Characterisation and Cytotoxic Potential

Recent patents on nanotechnology·2024

Related Experiment Video

Updated: May 12, 2026

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

4.2K

Development, Optimization, and Evaluation of Rutin-Loaded Liposomes in the Management of Rheumatoid Arthritis.

Gunjan Nautiyal1, Shiv Kant Sharma1, Dhirender Kaushik1

  • 1Department of Pharmaceutical Sciences, Gurugram University, Gurugram, 122018, India.

Current Drug Delivery
|January 15, 2025
PubMed
Summary

This study developed optimized rutin liposomes for rheumatoid arthritis treatment. The liposomal formulation demonstrated enhanced anti-inflammatory and antioxidant properties, offering improved therapeutic potential compared to free rutin.

Keywords:
Rheumatoid arthritisanti-inflammatoryantioxidantbox-behnken design.liposomesrutin

More Related Videos

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.0K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:49

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

76

Related Experiment Videos

Last Updated: May 12, 2026

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

4.2K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.0K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:49

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

76

Area of Science:

  • Nanotechnology and Pharmaceutical Sciences
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and cartilage destruction.
  • Nanotechnology offers novel approaches for targeted drug delivery in managing complex diseases like RA.
  • Rutin, a bioflavonoid, shows potential therapeutic benefits but requires effective delivery systems.

Purpose of the Study:

  • To formulate and optimize liposomes encapsulating the bioflavonoid rutin.
  • To evaluate the potential of rutin-loaded liposomes for rheumatoid arthritis management.

Main Methods:

  • Liposomes loaded with rutin were prepared using the thin-film hydration (Bangham) method.
  • Box-Behnken design was utilized for optimizing formulation parameters.
  • Characterization included particle size, zeta potential, morphology, XRD, DSC, and in-vitro antioxidant/anti-inflammatory assays.

Main Results:

  • An optimized batch (LP2) exhibited a mean particle size of 167.1 nm, zeta potential of -13.50 mV, and 61.22% entrapment efficiency.
  • Characterization confirmed spherical nanoparticles with good stability and a polycrystalline nature.
  • In-vitro assays demonstrated significant reduction in inflammation and protein denaturation, indicating potent antioxidant and anti-inflammatory effects.

Conclusions:

  • Rutin liposomal formulation shows significant potential for rheumatoid arthritis management.
  • Enhanced bioavailability and potent anti-inflammatory/antioxidant activities were observed compared to free rutin.
  • This nanocarrier system represents a promising strategy for RA therapy.